Medicure (MCUJF) Gains from Investment Securities (2009 - 2026)

Medicure's Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $10208.9 for Q1 2026.

• On a quarterly basis, Gains from Investment Securities fell 58.15% year-over-year to $10208.9 in Q1 2026; TTM through Mar 2026 was $85224.2, a 4.46% increase from a year earlier, with the FY2022 full-year figure at -$266131.5, up 81.5% from the prior year.
• Gains from Investment Securities slipped to $10208.9 in Q1 2026 per MCUJF's latest filing, from $15259.3 in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $231557.4 in Q3 2022 and bottomed at $5194.8 in Q1 2024.
• The 5-year median for Gains from Investment Securities is $24392.1 (2025), against an average of $48103.9.
• Across the five-year window, Gains from Investment Securities soared 6544.75% in 2022 and sank 83.09% in 2023, its largest moves.
• Year by year, Gains from Investment Securities stood at $32414.9 in 2022, then slumped by 45.23% to $17752.7 in 2023, then soared by 89.95% to $33720.5 in 2024, then slumped by 54.75% to $15259.3 in 2025, then slumped by 33.1% to $10208.9 in 2026.
• Per Business Quant, the three latest MCUJF Gains from Investment Securities figures stand at $10208.9 (Q1 2026), $15259.3 (Q3 2025), and $35363.9 (Q2 2025).